John P. Iwanicki discusses the Myriad Genetics case in a Financial Times article

June 15, 2012
Mr. Iwanicki discusses the status of the Myriad Genetics case in a Financial Times article titled “Biomedicine: No End in Sight for Cancer Gene.”

Posted: June 15, 2012

Contact Banner Witcoff Share on LinkedIn View this page as a pdf Share on Twitter Email this page Print this page